Results 71 to 80 of about 2,547 (172)
Bioresorbable stents: The future of interventional cardiology?
Cleveland Clinic Journal of Medicine, 2016 The introduction of stents has drastically reduced target-lesion restenosis rates associated with percutaneous coronary angioplasty. Bare-metal stents were the first introduced, followed by drug-eluting stents, both of which had significant impacts on the complication rates.
Stephen G, Ellis, Haris, Riaz
openaire +2 more sources
PLoS ONETo date, several types of airway stents are available to treat central airway obstructions. However, the ideal stent that can overcome anatomical, mechanical and microbiological issues is still awaited.
Sarah Schleich +11 more
doaj +1 more source
Bioresorbable-polymer Everolimus-eluting Stents
, 2022 Coronary artery disease is a leading cause of morbidity and mortality, with medical therapy and percutaneous coronary intervention forming the cornerstone of management. Early concerns over first and second generation stents have been overcome with device iterations. Platinum-chromium EES have mature clinical data and along with the cobalt-chromium EES
Thondapu, Vikas +5 more
openaire +3 more sources
3D-printed Bioresorbable Stent Coated with Dipyridamole-Loaded Nanofiber for Restenosis Prevention and Endothelialization. [PDF]
Int J Bioprint, 2022 Wang C +6 more
europepmc +1 more source
Late and Very Late Stent Thrombosis in the Era of Second Generation Drug Eluding Stents [PDF]
European Medical Journal, 2016 Stent thrombosis is a life-threatening complication of percutaneous coronary intervention that often results in ST-segment myocardial infarction or sudden cardiac death. First-generation drug-eluting stents (DESs) are associated with an increased risk of
Jaya Mallidi, Amir Lotf
doaj
Bioresorbable Stent to Manage Congenital Heart Defects in Children. [PDF]
Materialia (Oxf), 2021 Wright J +7 more
europepmc +1 more source
Bioresorbable Scaffolds: The Revolution in Coronary Stenting?
AIMS Medical Science, 2016 Bioresorbable scaffolds (BRS) represent the latest revolution in interventional cardiology. Thanks to their reabsorptive properties, they provide temporary scaffolding that helps stabilizing the plaque and promotes healing, and then disappear, thus restoring a functional endothelium and vasomotion.
Lorenzo Azzalini +2 more
openaire +2 more sources
Expandable Mg-based Helical Stent Assessment using Static, Dynamic, and Porcine Ex Vivo Models
Scientific Reports, 2017 A bioresorbable metallic helical stent was explored as a new device opportunity (magnesium scaffold), which can be absorbed by the body without leaving a trace and simultaneously allowing restoration of vasoreactivity with the potential for vessel ...
Youngmi Koo +3 more
doaj +1 more source
Advances in Interventional Cardiology, 2016 Introduction: There are limited data on the comparison of bioresorbable vascular scaffold (BVS) and drug-eluting stent (DES)/bare-metal stent (BMS) implantation in an unselected population of patients with coronary artery disease.
Łukasz Rzeszutko +5 more
doaj +1 more source
The unpredictable resorption of bioresorbable scaffolds—A tale of two ABSORBs
Clinical Case ReportsBioresorbable stents represent a revolutionary treatment for coronary artery disease. Such a device offers the prospect for complete naturalization of artery lumen after strut resorption and restoration of vasomotion while curtailing the duration of dual
Akshyaya Pradhan +6 more
doaj +1 more source